Rapid Cardiac Panel Test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of cardiac troponin I (cTnI), CK-MB and Myoglobin in human serum, plasma or whole blood as an aid in the diagnosis of myocardial infarction.
Acute myocardial infarction (AMI) is a serious life-threatening and common heart disease that is based on coronary atherosclerosis. Heart failure (HF) refers to the decline in cardiac function, which fails to meet the need of peripheral blood circulation. AMI and HF have become the most common kinds of vascular diseases endangering human health. Detecting cTnI, CK-MB and Myoglobin levels together can significantly contribute to the early diagnosis of heart failure and acute myocardial infarction. It can also provide diagnostic evidence to clinic and thus lower the mortality of AMI and HF.